Sign Up to like & get
recommendations!
0
Published in 2017 at "Scientific Reports"
DOI: 10.1038/s41598-017-03143-8
Abstract: Cyclin D1, a G1-S phase regulator, is upregulated in parathyroid adenomas. Since cyclin-dependent kinase (CDK) inhibitors, CDKN2A and CDKN2B, and RASSF1A (Ras-association domain family 1, isoform A) are involved in G1-S phase arrest and act…
read more here.
Keywords:
parathyroid adenomas;
cdkn2b rassf1a;
cdkn2a cdkn2b;
promoter ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Cold Spring Harbor Molecular Case Studies"
DOI: 10.1101/mcs.a006164
Abstract: Germline pathogenic variants in CDKN2A predispose to various cancers, including melanoma, pancreatic cancer, and neural system tumors, whereas CDKN2B variants are associated with renal cell carcinoma. A few case reports have described heterozygous germline deletions…
read more here.
Keywords:
involving cdkn2a;
9p21 microdeletion;
microdeletion involving;
primary cancers ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-207095
Abstract: The Richter Syndrome (RS) genomic landscape is characterized by frequent loss-of-function (LOF) genetic lesions in negative cell-cycle regulators, such as the cyclin dependent kinase (CDK) inhibitors CDKN2A and CDKN2B, which are deleted in 40-50% of…
read more here.
Keywords:
mice;
genetic lesions;
cell;
tp53 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2025.1437093
Abstract: Chromosome 9p21.3 is a locus associated with a rare autosomal dominant cancer predisposition syndrome characterized by early-onset melanoma and a broad spectrum of neural system tumors. Two major tumor-suppressor genes, cyclin-dependent kinase inhibitor 2A and…
read more here.
Keywords:
plexiform neurofibromas;
cdkn2b;
involving cdkn2a;
cdkn2a ... See more keywords